TP53 and neoplasm: In breast cancer, mutated TP53 can cause loss of ability to regulate TNF signaling, followed by NF‐kB activation and a perpetuated inflammatory cycle, linked to recruitment of immune cells within the tumor (Di Minin et al., 2014).